Chinese Clinical Oncology

• 综述与讲座 • Previous Articles     Next Articles

The progression of regulatory T cells and tumor immunity

XIE Dacheng, WANG Liwei.

  

  1. Department of Medical Oncology,First Peoples Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, China
  • Received:2013-03-12 Revised:2013-04-24 Online:2013-06-30 Published:2013-06-30
  • Contact: WANG Liwei

Abstract: Regulatory T cells(Treg) play a dominant role in selftolerance and control of autoimmune diseases. These cells also play a pivotal role in chronic inflammation and cancer by limiting immune activation and specific immune response. The study shows Treg can be divided into two subsets including natural(n) Treg and inducible(i) Treg. Natural(n) Treg is normally responsible for maintaining peripheral tolerance and immune balance in healthy individuals. Inducible(i) Treg is highly suppressive, therapy-resistant Treg which down-regulate anti-tumor immune responses and promote tumor growth. But this division of labor between nTreg and iTreg is not absolute, and overlap may be common. This review is aim to discuss the phenotypic diversity and plasticity of the Treg, and then investigate the relationship between Treg and tumor prognosis and immunity therapy.

No related articles found!
Viewed
Full text
515
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 515

  From Others local
  Times 45 470
  Rate 9% 91%

Abstract
141
Just accepted Online first Issue
0 0 141
  From Others
  Times 141
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!